gelle005@umn.edu Dr. Geller is Assistant Professor in the Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology, joining our faculty in 2005. Dr. Geller is a board certified Gynecologic Oncologist.
Dr. Geller graduated cum laude with honors in Biology from Boston College. She received her medical degree at Chicago Medical School Finch University of Health Sciences and completed her residency in Obstetrics and Gynecology at the University of Minnesota. She conducted a fellowship in gynecologic oncology surgery at Memorial-Sloan Kettering Cancer Center followed by a fellowship in gynecologic oncology at the University of Minnesota.
Research Interests
Dr. Geller's clinical interests are ovarian cancer and the treatment of uterine sarcomas. Dr. Geller received the CAPS Award which she will use to study gene microarray patterns in ovarian cancer. Her active research interests are as follows:
1. MCP-1 (Macrophage Chemotactic Protein-1) levels in patients with newly diagnosed ovarian cancer receiving chemotherapy
2. Women's Cancer Center Protocol #38: A Phase II trial of induction carboplatin and docetaxel followed by radiotherapy then consolidation chemotherapy with carboplatin and docetaxel in Stage II, IV and recurrent endometrial cancer.
3. Alterations in Serotonin (5-HT) signaling as a mechanism for chemotherapy induced constipation in ovarian cancer patients.
4. Use of multimedia materials for educational materials for women with newly-diagnosed ovarian cancer.
Selected Publications
Ghosh K, Geller MA, Twiggs LB. Erosion of an intraperitoneal chemotherapy catheter resulting in an enterovaginal fistula. Gynecol Oncol 2000;77(2):327-9.
Judson PL, Geller MA, Bliss RL, Boente MP, Downs LS Jr, Argenta PA, Carson LF. Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer. Gynecol Oncol 2003;91(2):389-94.
Geller MA, Argenta P, Bradley W, Dusenbery KE, Brooker D, Downs LS Jr, Judson PL, Carson LF, Boente MP. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression. Gynecol Oncol 2004;95(3):632-6.
Ramakrishnan S, Subramanian IV, Yokoyama Y, Geller M. Angiogenesis in normal and neoplastic ovaries. Angiogenesis 2005;8(2):169-82.
Chura JC, Truskinovsky AM, Judson PL, Johnson L, Geller MA, Downs LS Jr. Positron emission tomography and leiomyomas: Clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review. Gynecol Oncol 2007;104(1):247-52.
Leath CA III, Huh WK, Hyde J Jr, Cohn DE, Resnick KE, Taylor NP, Powell MA, Mutch DG, Bradley WH, Geller MA, Argenta PA, Gold MA. A multi-institutional review of outcomes of endometrial stromal sarcoma. Gynecol Oncol 2007;105(3):630-4.
Chura JC, Marushin R, Boyd A, Ghebre R, Geller MA, Argenta PA. Multimodal therapy improves survival in patients with CNS metastasis from uterine cancer: A retrospective analysis and literature review. Gynecol Oncol. 2007;107(1):79-85.
Downs LS Jr, Judson PL, Argenta PA, Ghebre R, Geller MA, Bliss RL, Boente MP, Nahhas WA, Abu-Ghazaleh SZ, Chen MD, Carson LF. A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma. Cancer 2008;112(2):331-9.
Clinics